FERASET, a leading app company based in Istanbul and renowned for its dedication to building AI-powered apps with lasting impact, is thrilled to announce that it has successfully raised 4,500,000 dollars in its latest funding round. This substantial investment is a testament to the company’s innovative approach and its ability to disrupt the tech landscape with groundbreaking solutions. The funds will be channelled into accelerating research and development efforts, expanding the talented team of engineers and data scientists, and enhancing the overall user experience by integrating advanced AI features into FERASET’s suite of applications. With this new capital at its disposal, FERASET is poised to enhance its product offerings and explore new markets, all while maintaining its commitment to innovation and excellence. The company’s leadership team views this funding milestone as a significant stepping stone that not only validates its vision but also enables it to take bold strides towards redefining the future of AI-powered applications. In the competitive tech market, where agility and forward-thinking solutions are paramount, FERASET’s decision to invest in cutting-edge technology and talent will position it to deliver even more impactful digital experiences to its users. As the company forges ahead, it remains focused on making technology more accessible and practical, promising to continue its legacy as a driving force in the evolution of smart, interactive app ecosystems. This funding is not just an investment in technology—it’s an investment in a future where intelligent applications help empower businesses and individuals alike.
FERASET Secures $4.5M Seed Round to Power AI-Driven Success in Istanbul
Recently funded · $4.5M SeedSoftware Development
Get the full FERASET company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Candid Health
Remake your health insurance claims process with Candid Health – a transformative RCM automation platform, custom built for medical providers to end unnecessary human intervention. Increase net collections, reduce cost to collect, and accelerate cash flow with Candid.
$120.0M Series d
today
Plantopia Bio.
At Plantopia, we are pioneering a new era in sustainable protein production. Leveraging our proprietary "Plant as a Platform" technology, we transform plants into efficient and scalable bio-factories capable of producing complex functional proteins. Our innovative approach combines advances in molecular farming, controlled-environment agriculture, and plant genetics to deliver high-quality solutions that are cost-effective, sustainable, and versatile. The world faces significant challenges in meeting the growing demand for protein, with traditional animal-based and alternative production methods often falling short due to high costs, inefficiency, and environmental impact. Plantopia addresses these challenges head-on by reimagining how essential biocompounds are produced. Our plant-based solutions reduce resource consumption, environmental strain, and production costs while maintaining the quality and functionality of traditional proteins. Our first breakthrough is in producing plant-based casein, a protein essential to the functionality of dairy products, with applications in cheese and beyond. Identical in structure and functionality to its animal-derived counterpart, our casein unlocks new possibilities for plant-based dairy alternatives without compromising on taste or texture. Backed by a team of industry veterans and leading investors in food-tech, Plantopia is at the forefront of reshaping the future of food production. Join us as we pave the way for a sustainable, healthier planet by turning plants into powerful tools for innovation. Let’s grow a better future together.
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Auditstage Belgium | Seed | $2.3M | today |
| 2 |  Bioscan Research India | Seed | $1.0M | today |
